Celivarone

Drug Profile

Celivarone

Alternative Names: SSR 149744; SSR 149744B; SSR 149744C

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi-aventis
  • Developer Sanofi
  • Class Antiarrhythmics; Benzofurans
  • Mechanism of Action Ion channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Supraventricular arrhythmias; Ventricular arrhythmias

Most Recent Events

  • 31 Dec 2011 Discontinued - Phase-II for Ventricular arrhythmias in Argentina (PO) during 2011
  • 31 Dec 2011 Discontinued - Phase-II for Ventricular arrhythmias in Australia (PO) during 2011
  • 31 Dec 2011 Discontinued - Phase-II for Ventricular arrhythmias in Belgium (PO) during 2011
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top